Latest News - CRSTodayEurope

Friday, December 15, 2017 | Glaucoma, Medical Studies

Brewing Health Benefits: Hot Tea May Lower Glaucoma Risk

Hot tea may do more than warm your insides: Drinking at least one cup of caffeinated tea a day may lower a person's risk for glaucoma, a new study suggests, as reported in Live Science. Researc…

Read the full story

Friday, December 15, 2017 | Earnings & Financials, Presbia

Presbia Announces Board and Management Changes and Financing Proposal to Operate Through to the End of 2018

Presbia announced that it has reordered its operational priorities to focus its resources on FDA approval as well as ongoing clinical and commercial efforts in Germany and South Korea. These actions r…

Read the full story

Friday, December 15, 2017 | Miscellaneous, Bausch+Lomb

In Letter to Customers, B+L Reviews Innovations, Preview What's Next

Chuck Hess, Vice President & General Manager, U.S. Surgical, Bausch + Lomb, sent the following letter to customers reviewing some of the innovations the company introduced in 2017, and previewing …

Read the full story

Friday, December 15, 2017 | Clinical Trials

Aura Biosciences Announces Publication of Preclinical Data Supporting AU-011’s Potent and Selective Anti-Cancer Activity in Ocular Melanoma Tumors

Aura Biosciences, announced that researchers at Massachusetts Eye and Ear (MEE), Emory University and the National Cancer Institute (NCI) have generated preclinical data that demonstrate the…

Read the full story

Thursday, December 14, 2017 | Medical Studies

Analysis Points to Declining Returns on R&D for Pharmaceutical Companies

The pharmaceutical industry continues to face an extremely challenging R&D environment and has yet to turn a corner in terms of its R&D value proposition, according to a new study releas…

Read the full story

Thursday, December 14, 2017 | Earnings & Financials

Teva's New CEO to Cut 25% of Jobs to Rescue Ailing Drugmaker

Teva Pharmaceutical Industries announced some of the most sweeping job cuts in the drug industry, eliminating 14,000 positions globally as new Chief Executive Officer Kare Schultz seeks to stabilize a…

Read the full story

Thursday, December 14, 2017 | Conferences, Optometry

American Academy of Optometry Announces The Research Academy to Encourage Research Funding in Optometry and Vision Science

The American Academy of Optometry is proud to announce a new program, The Research Academy, to be held in Columbus, Ohio, July 17-19, 2018. The goal of The Research Academy is to help optometry facult…

Read the full story

Wednesday, December 13, 2017 | Optometry, Johnson & Johnson Vision Care

Johnson & Johnson's Peter Menziuso and AOA’s Dr. Chris Quinn on the Ground in Washington

Representing Johnson & Johnson Vision, Peter Menziuso joined American Optometric Association (AOA) President Dr. Chris Quinn yesterday in Washington, DC, for meetings at the FDA and…

Read the full story

Wednesday, December 13, 2017 | Patents, SciFluor Life Sciences

SciFluor Announces 6 New Patent Issuances Covering the Use of SF0166 Topical Ophthalmic Solution in Retinal Diseases

SciFluor Life Sciences announced that the European Patent Office has issued a patent (EP 2953948) for SF0166, a novel potent and selective small molecule inhibitor of integrin αvβ3, in reti…

Read the full story

Wednesday, December 13, 2017 | Medical Studies

Artificial Intelligence Eyed as Diabetic Retinopathy Screen

A computing system using artificial intelligence is highly accurate in identifying people with diabetes who have diabetic retinopathy and related eye diseases and need to be referred for further care,…

Read the full story

Tuesday, December 12, 2017 | Medical Studies

Mount Sinai Researchers Use Breakthrough Technology to Further Understand Eye Damage from Eclipse

In a first-of-its-kind study, Mount Sinai researchers are using adaptive optics (AO) to analyze retinal eye damage from the August solar eclipse on a cellular level. The research could help doctors de…

Read the full story

Tuesday, December 12, 2017 | Product Releases

New Educational Resource Offers Important Advice on Choosing the Right Eye Drop

There are a number of safe and effective over-the-counter eye drops available to relieve various types of eye discomfort, such as dry eyes, red eyes, eyes irritated by allergies or contact lens wear, …

Read the full story

Tuesday, December 12, 2017 | Cataract Surgery, FDA Approval/Clearance, Omeros

Omeros Announces FDA Approval of Omidria for Use in Pediatric Patients

The FDA has approved Omeros’ supplemental new drug application that expands the indication of Omidria (phenylephrine and ketorolac intraocular solution) 1%/0.3% to include use in pediatric patie…

Read the full story

Tuesday, December 12, 2017 | Management/Leadership

Eyevensys Appoints Patricia Zilliox, PhD, as Chief Executive Officer

Eyevensys, a clinical stage biotech company developing non-viral gene therapies for ophthalmic diseases, announced the appointment of Patricia Zilliox. PhD, as CEO. Dr. Zilliox, who joined the Eyev…

Read the full story

Tuesday, December 12, 2017 | Clinical Trials

Realm Therapeutics Announces First Patient Dosed in Phase 2 Study of PR013 for the Treatment of Allergic Conjunctivitis

Realm Therapeutics announced the first patient has been dosed in its phase 2 study of PR013, the company's topical ophthalmic formulation of high concentration hypochlorous acid, for the treatment…

Read the full story
Load More